CN100338066C - 六环化合物 - Google Patents

六环化合物 Download PDF

Info

Publication number
CN100338066C
CN100338066C CNB028277465A CN02827746A CN100338066C CN 100338066 C CN100338066 C CN 100338066C CN B028277465 A CNB028277465 A CN B028277465A CN 02827746 A CN02827746 A CN 02827746A CN 100338066 C CN100338066 C CN 100338066C
Authority
CN
China
Prior art keywords
ethyl
pyrido
pyrano
quinazoline
indolizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028277465A
Other languages
English (en)
Chinese (zh)
Other versions
CN1617874A (zh
Inventor
村田毅
新妻谕
新间信夫
须田仁三
塚崎雅雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN1617874A publication Critical patent/CN1617874A/zh
Application granted granted Critical
Publication of CN100338066C publication Critical patent/CN100338066C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB028277465A 2001-11-30 2002-11-25 六环化合物 Expired - Fee Related CN100338066C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128361.1 2001-11-30
EP01128361 2001-11-30

Publications (2)

Publication Number Publication Date
CN1617874A CN1617874A (zh) 2005-05-18
CN100338066C true CN100338066C (zh) 2007-09-19

Family

ID=8179394

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028277465A Expired - Fee Related CN100338066C (zh) 2001-11-30 2002-11-25 六环化合物

Country Status (28)

Country Link
US (2) US6825194B2 (https=)
EP (1) EP1480984B9 (https=)
JP (1) JP4305909B2 (https=)
KR (1) KR100895746B1 (https=)
CN (1) CN100338066C (https=)
AT (1) ATE398131T1 (https=)
AU (1) AU2002356720B2 (https=)
BR (1) BR0214615A (https=)
CA (1) CA2468824C (https=)
DE (1) DE60227113D1 (https=)
ES (1) ES2307830T3 (https=)
GT (1) GT200200250A (https=)
HU (1) HUP0500062A3 (https=)
IL (1) IL162058A0 (https=)
MX (1) MXPA04005185A (https=)
MY (1) MY136138A (https=)
NO (1) NO329005B1 (https=)
NZ (1) NZ533568A (https=)
PA (1) PA8558901A1 (https=)
PE (1) PE20030725A1 (https=)
PL (1) PL207510B1 (https=)
RS (1) RS51051B (https=)
RU (1) RU2299212C2 (https=)
TW (1) TWI258481B (https=)
UA (1) UA80409C2 (https=)
UY (1) UY27560A1 (https=)
WO (1) WO2003045952A2 (https=)
ZA (1) ZA200404522B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595400B2 (en) 2003-02-21 2009-09-29 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of hexacyclic compounds
TWI351284B (en) 2004-04-09 2011-11-01 Chugai Pharmaceutical Co Ltd Novel water-soluble prodrugs
TW200744603A (en) * 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
US20090118271A1 (en) * 2005-10-19 2009-05-07 Chugai Seiyaku Kabushiki Kaisha Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug
RU2439073C1 (ru) * 2010-07-13 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ИНДОЛИЗИНО[7,6-b]ИНДОЛА
MX2021011812A (es) 2019-03-29 2021-10-22 Medimmune Ltd Compuestos y conjugados de estos.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0559061A (ja) * 1991-01-16 1993-03-09 Dai Ichi Seiyaku Co Ltd 六環性化合物
CN1123548A (zh) * 1994-02-16 1996-05-29 药制品公司 喜树碱衍生物及其制备方法
US6093721A (en) * 1997-07-25 2000-07-25 Pharmacia & Upjohn S.P.A. Amidino-camptothecin derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
ES2262223T3 (es) 1997-02-14 2006-11-16 Bionumerik Pharmaceuticals, Inc. Derivados de camptotecina altamente lipofilos.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0559061A (ja) * 1991-01-16 1993-03-09 Dai Ichi Seiyaku Co Ltd 六環性化合物
CN1123548A (zh) * 1994-02-16 1996-05-29 药制品公司 喜树碱衍生物及其制备方法
US6093721A (en) * 1997-07-25 2000-07-25 Pharmacia & Upjohn S.P.A. Amidino-camptothecin derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Syntheis and antitumor activity of a new class of water solublecamptothecin derivatives A. BEDESCHI ET AL,BIOORG. MED. CHEM. LETT,Vol.6 No.6 1996 *
Synthesis and Antitumor Activity of Ring A-and F-ModifiedHexacyclic Camptothecin Analogues M. SUGIMORI ET AL,J. MED. CHEM,Vol.41 No.13 1998 *

Also Published As

Publication number Publication date
AU2002356720B2 (en) 2009-01-29
CA2468824A1 (en) 2003-06-05
RS51051B (sr) 2010-10-31
US20050059679A1 (en) 2005-03-17
BR0214615A (pt) 2004-09-14
JP4305909B2 (ja) 2009-07-29
NZ533568A (en) 2006-01-27
US6825194B2 (en) 2004-11-30
MXPA04005185A (es) 2004-08-11
ES2307830T3 (es) 2008-12-01
MY136138A (en) 2008-08-29
ZA200404522B (en) 2005-01-04
NO329005B1 (no) 2010-07-19
WO2003045952A3 (en) 2003-10-16
RS47004A (sr) 2007-02-05
IL162058A0 (en) 2005-11-20
RU2004119841A (ru) 2005-03-27
AU2002356720A1 (en) 2003-06-10
TWI258481B (en) 2006-07-21
KR20040062976A (ko) 2004-07-09
US20030144304A1 (en) 2003-07-31
CA2468824C (en) 2011-01-11
GT200200250A (es) 2004-01-15
TW200408642A (en) 2004-06-01
HK1077303A1 (en) 2006-02-10
HUP0500062A2 (hu) 2005-04-28
DE60227113D1 (de) 2008-07-24
WO2003045952A2 (en) 2003-06-05
JP2005511643A (ja) 2005-04-28
CN1617874A (zh) 2005-05-18
EP1480984B1 (en) 2008-06-11
UY27560A1 (es) 2003-05-30
ATE398131T1 (de) 2008-07-15
HK1072935A1 (en) 2005-09-16
PA8558901A1 (es) 2003-06-30
NO20042729L (no) 2004-08-27
PE20030725A1 (es) 2003-08-28
RU2299212C2 (ru) 2007-05-20
EP1480984B9 (en) 2009-03-11
PL370479A1 (en) 2005-05-30
HUP0500062A3 (en) 2012-12-28
PL207510B1 (pl) 2010-12-31
UA80409C2 (en) 2007-09-25
KR100895746B1 (ko) 2009-04-30
EP1480984A2 (en) 2004-12-01
US7109195B2 (en) 2006-09-19

Similar Documents

Publication Publication Date Title
CN1139592C (zh) 喜树碱衍生物，其制备用途以及中间体
CN1122668C (zh) 环氧噻酮衍生物，其制备方法及其药物组合物
CN1027265C (zh) 水溶性喜树碱类似物的制备方法
CN100347185C (zh) 新的无环核苷膦酸酯衍生物,其盐及其制备方法
CN1186324C (zh) 稠合杂芳基衍生物
CN1492860A (zh) 喹唑啉衍生物
CN1246323C (zh) 氮基喜树碱衍生物
CN1198827C (zh) 精选的K－252a衍生物
CN1553802A (zh) 喜树碱衍生物
CN1918160A (zh) 用作趋化因子受体活性调节剂的新颖三环螺环衍生物
CN1675220A (zh) 埃坡霉素衍生物
CN1956982A (zh) 具有氨基噻唑骨架的Cdk4、6选择性抑制剂
CN1031532A (zh) 杂环化合物
CN1893944A (zh) 具有抗增殖活性的3－氰基喹啉衍生物
CN1227254C (zh) 吡啶酮化合物及其制备方法
CN100338066C (zh) 六环化合物
CN1921867A (zh) 用于治疗hiv感染的膦酸核苷衍生物
CN1777611A (zh) 制备六环喜树碱衍生物的方法
HK1045514A1 (en) Optically pure camptothecin analogues and composition and use thereof
CN1086188C (zh) 新颖的菲啶鎓衍生物
HK1077303B (en) Hexacyclic compounds
CN1147491C (zh) 新的吖啶羧酸酯化合物、其制备方法及其药物组合物
CN1284781C (zh) 具有抗肿瘤活性的多环化合物
CN1304380C (zh) 苯并[a]吩嗪－11－酰胺衍生物及它们作为拓扑异构酶Ⅰ和Ⅱ的联合抑制剂的用途
CN1289502C (zh) 苯并[a]吡喃并[3，2－h]吖啶－7－酮化合物、其制备方法及其药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1077303

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1077303

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070919

Termination date: 20121125